- Home
- WYY vs INCR Comparison
WYY vs INCR Comparison
Compare WYY & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYY
- INCR
- Stock Information
- Founded
- WYY 1991
- INCR 1994
- Country
- WYY United States
- INCR Israel
- Employees
- WYY N/A
- INCR N/A
- Industry
- WYY EDP Services
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- WYY Technology
- INCR Health Care
- Exchange
- WYY Nasdaq
- INCR Nasdaq
- Market Cap
- WYY 54.9M
- INCR 65.3M
- IPO Year
- WYY 1998
- INCR N/A
- Fundamental
- Price
- WYY $4.87
- INCR $1.68
- Analyst Decision
- WYY Strong Buy
- INCR
- Analyst Count
- WYY 1
- INCR 0
- Target Price
- WYY $7.00
- INCR N/A
- AVG Volume (30 Days)
- WYY 123.8K
- INCR 54.5K
- Earning Date
- WYY 11-13-2024
- INCR 02-15-2025
- Dividend Yield
- WYY N/A
- INCR N/A
- EPS Growth
- WYY N/A
- INCR N/A
- EPS
- WYY N/A
- INCR N/A
- Revenue
- WYY $133,124,648.00
- INCR $72,420,918.00
- Revenue This Year
- WYY $25.94
- INCR N/A
- Revenue Next Year
- WYY $13.22
- INCR $39.30
- P/E Ratio
- WYY N/A
- INCR N/A
- Revenue Growth
- WYY 31.67
- INCR N/A
- 52 Week Low
- WYY $1.83
- INCR $1.17
- 52 Week High
- WYY $6.25
- INCR $3.72
- Technical
- Relative Strength Index (RSI)
- WYY 50.68
- INCR 60.58
- Support Level
- WYY $3.88
- INCR $1.34
- Resistance Level
- WYY $4.97
- INCR $1.79
- Average True Range (ATR)
- WYY 0.52
- INCR 0.08
- MACD
- WYY -0.14
- INCR 0.05
- Stochastic Oscillator
- WYY 41.77
- INCR 77.55
About WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically the company generates a majority of its revenue from the United States and rest from Europe.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.